Bank Of America Corp Argenx Se Transaction History
Bank Of America Corp
- $1.33 Trillion
- Q2 2025
A detailed history of Bank Of America Corp transactions in Argenx Se stock. As of the latest transaction made, Bank Of America Corp holds 336,120 shares of ARGX stock, worth $266 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
336,120
Previous 340,115
1.17%
Holding current value
$266 Million
Previous $201 Million
7.96%
% of portfolio
0.01%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding ARGX
# of Institutions
491Shares Held
28.3MCall Options Held
370KPut Options Held
211K-
Price T Rowe Associates Inc Baltimore, MD4.98MShares$3.94 Billion0.31% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$2.21 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.57MShares$2.03 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.54 Billion0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.18MShares$930 Million11.81% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $43.8B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...